IL-6 pre-treatment protects cardiomyocytes against ischemia/reperfusion injury through PI 3-kinase and NO-dependent pathways that preserve mitochondrial function.
No takes yet. Share an insight, caveat, or question.
IL-6 pretreatment may confer cardiomyocyte protection in animals; leaves open clinical translation and requires prospective human studies.
Smart et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: